Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
| ▸ | PRKDC | P78527 | 5/20 | 0.36 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.33 |
| ▸ | PTPRF | P10586 | 2/20 | 0.30 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.30 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23947787 | 0.93 | PRKDC (0.36) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL24264009 | 0.92 | PRKDC (0.42) | ALOX5PRKDCPIK3CDPIK3CBSIRT2 | |
| SCHEMBL24216124 | 0.91 | ALOX5 (0.40) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL24230966 | 0.91 | PRKDC (0.35) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL22258040 | 0.90 | PRKDC (0.33) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL23947910 | 0.90 | ALOX5 (0.36) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL20754177 | 0.88 | ALOX5 (0.38) | ALOX5PRKDCPTPRFPTPN2PTPN1 | |
| SCHEMBL24216524 | 0.88 | ALOX5 (0.47) | ALOX5PRKDCPIK3CDPIK3CBBRD4 | |
| SCHEMBL23947318 | 0.88 | PRKDC (0.40) | ALOX5PRKDCPIK3CDPIK3CBSIRT2 | |
| SCHEMBL20922227 | 0.88 | PRKDC (0.33) | ALOX5PRKDCPIK3CDPIK3CBBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220123224-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-21 | — | — | US | disclosed |
| WO-2020045831-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | 덕산네오룩스 주식회사 | 2020-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220123224-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | PIEZO1, OR51E2, OR10J3 | ALOX5 849/4885PRKDC 3860/4885PIK3CD 3212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.